Radiat Oncol J.  2016 Sep;34(3):209-215. 10.3857/roj.2016.01739.

Organ preservation with neoadjuvant chemoradiation in patients with orbit invasive sinonasal cancer otherwise requiring exenteration

• Amsbaugh M
• Yusuf M
• Silverman
• Bumpous J
• Perez CA
• Potts K
• Tennant P
• Redman R
• Dunlap N

• KMID: 2356117
• DOI: http://doi.org/10.3857/roj.2016.01739

Abstract

PURPOSE
We sought to determine if organ preservation (OP) with neoadjuvant chemoradiation (CRT) was feasible in patients with sinonasal cancer determined to require exenteration.
MATERIALS AND METHODS
Twenty patients were determined to require exenteration for definitive treatment from 2005 to 2014. Fourteen patients underwent OP and 6 patients received exenteration with adjuvant CRT. Exenteration free survival (EFS), locoregional control (LRC), progression-free survival (PFS), and overall survival (OS) were estimated.
RESULTS
Five patients (36%) receiving OP had complete disease response at time of surgery. With a median follow-up of 18.8 months, EFS was 62% at 2 years for patients undergoing OP. At 2 years, there were no significant differences in LRC, PFS or OS (all all p > 0.050) between the groups. Less grade 3 or greater toxicity was seen in patients undergoing OP (p = 0.003). Visual function was preserved in all patients undergoing OP.
CONCLUSION
For patients with sinonasal cancer, OP may avoid exenteration, offering similar disease control and improved toxicity.

Keyword

Sinonasal; Neoadjuvant; Organ preservation; Orbit; Exenteration

MeSH Terms

Disease-Free Survival
Follow-Up Studies
Humans
Orbit*
Organ Preservation*